Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing

Respiratory Medicine

Volumn 98, Issue 12, 2004, Pages 1180-1186

  Valipour, Arschang ^a,d   Litschauer, Brigitte ^b   Mittermayer, Friedrich ^b   Rauscher, Helmuth ^c   Burghuber, Otto Chris ^a   Wolzt, Michael ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c GENERAL HOSPITAL LINZ   (Austria)

^d NONE   (Austria)

Author keywords

Hypoxemia; Obstructive sleep apnea; Sleep disordered breathing; VEGF

Indexed keywords

FIBRINOGEN; THROMBIN; VASCULOTROPIN;

ADOLESCENT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; NIGHT; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT PARAMETERS; SCHOOL CHILD; SLEEP APNEA SYNDROME; SLEEP TIME; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BODY MASS INDEX; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 8644237459     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.04.009     Document Type: Article

References (28)

1. Peppard P.E. Young T. Palta M. Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension N Engl J Med 342 2000 1378-1384
2. Shahar E. Whitney C.W. Redline S. Lee E.T. Newman A.B. Nieto F.J. O'Connor G.T. Boland L.L. Schwartz J.E. Samet J.M. Sleep disordered breathing and cardiovascular disease: Cross-sectional results from the sleep heart health study Am J Respir Crit Care Med 163 2001 19-25
3. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis Am J Physiol Cell Physiol 280 2001 C1358-C1366
4. Minchenko A. Bauer T. Salceda S. Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo Lab Invest 71 3 1994 374-379
5. Inoue M. Itoh H. Ueda M. et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis Circulation 98 20 1998 2108-2116
6. Maloney J. Wang D. Duncan T. Voelkel N. Rouss S. Plasma vascular endothelial growth factor in acute mountain sickness Chest 118 2000 47-52
7. Gunga H.C. Kirsch K. Röcker L. Behn C. Koralewski E. Davila E.H. Estrada M.I. Johannes B. Wittels P. Jelkmann W. Vascular endothelial growth factor in exercising humans under different environmental conditions Eur J Appl Physiol Occup Physiol 79 6 1999 484-490
8. Pavlicek V. Marti H.H. Grad S. Gibbs J.S.R. Kol C. Wenger R.H. Gassmann M. Kohl J. Maly F.E. Oelz O. Koller E.A. Schirlo C. Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema Eur J Appl Physiol 81 6 2000 497-503
9. Walter R. Maggiorini M. Scherrer U. Contesse J. Reinhart W.H. Effects of high-altitude exposure on vascular endothelial growth factor levels in man Eur J Appl Physiol 85 1-2 2001 113-117
10. Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, Suzuki N, Yamamoto M, Nagasawa T. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 2001; 15,98(4):1255-7
11. Schulz R. Hummel C. Heinemann S. Seeger W. Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia Am J Respir Crit Care Med 165 1 2002 67-70
12. Gozal D. Lipton A.J. Jones K.L. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea Sleep 25 1 2002 59-65
13. Teramoto S. Kume H. Yamamoto H. Ishii T. Miyashita A. Matsuse T. Akishita M. Toba K. Ouchi Y. Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome Intern Med 42 2003 681-685
14. Webb NJA, Bottomley, Watson CJ, Brenchley PEC. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 1998; 94: 395-404
15. George M.L. Eccles S.A. Tutton M.G. Abulafi A.M. Swift R.I. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging? Clin Cancer Res 6 2000 3147-3152
16. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor Clin Chem 47 4 2001 617-623
17. PhPllipson EA, Bowes G. Sleep disorders. In: Update: pulmonary diseases and disorders. New York: McGraw-Hill; 1982. p. 256-73
18. American Sleep Disorders Association (ASDA) Report. EEG-arousals: scoring rules and examples. A preliminary report from the Sleep Disorders Atlas Task Force of the ASDA. Sleep 1992;15:174-84
19. Miyazawa-Hoshimoto S. Takahashi K. Bujo H. Hashimoto N. Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects Diabetologia 46 2003 1483-1488
20. Verheul H.M. Hoekman K. Luykx-de Bakker S. Eekman C.A. Folman C.C. Broxterman H.J. Pinedo H.M. Platelet: Transporter of vascular endothelial growth factor Clin Cancer Res 3 1997 2187-2190
21. Gunsilius E. Petzer A. Stockhammer G. Nussbaumer W. Schumacher P. Clausen J. Gastl G. Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood Oncology 58 2000 169-174
22. Lavie L. Kraiczi H. Hefetz A. Ghandour H. Perelman A. Hedner J. Lavie P. Plasma vascular endothelial growth factor in sleep apnea syndrome: Effects of nasal continuous positive air pressure treatment Am J Respir Crit Care Med 165 12 2002 1624-1628
23. Koehne P. Willam C. Strauss E. Schindler R. Eckardt K.U. Bührer C. Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets Am J Physiol Heart Circ Physiol 279 2000 H817-H824
24. Schultz A. Lavie L. Hochberg I. Beyar R. Stone T. Skorecki K. Lavie P. Roguin A. Levy A.P. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation Circulation 100 5 1999 547-552
25. Goldberg M.A. Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin J Biol Chem 269 1994 4355-4359
26. Cohen T. Nahari D. Cerem L.W. Neufeld G. Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor J Biol Chem 271 2 1996 736-741
27. Kanabrocki E.L. Sothern R.B. Messmore H.L. Roitman-Johnson B. McCormick J.B. Dawson S. Bremner F.W. Third J.L. Nemchausky B.M. Shirazi P. Scheving L.E. Circadian interrelationships among levels of plasma fibrinogen, blood platelets,and serum interleukin-6 Clin Appl Thromb Hemost 5 1 1999 37-42
28. Belgore F.M. Blann A.D. Li-Saw-Hee Fl. Beevers D.G. Lip G.Y. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension Am J Cardiol 87 6 2001 805-807